T cells play a major role in producing adaptive immune responses to microbes and cancers. T-cell development occurs in the thymus, starting from hematopoietic stem cells. There, CD4 -
CD8
-double-negative (DN) thymocytes that generate a functional T-cell receptor (TCR) β-chain express on their surface the pre-TCR (preTCR). Unlike the TCR itself, which comprises an α-chain and a β-chain, the preTCR consists of a TCR β-chain and an invariant preTCR α-chain (pTα) (1) (Fig. 1A) . Both the TCR and preTCR are associated with CD3 molecules, which transduce activation signals to the cell. The reason the preTCR lacks a TCR α-chain is that TCRβ gene rearrangements precede those of TCRα genes. Expression of the preTCR enables DN cells with productive TCRβ rearrangements to differentiate into CD4 +
+ double-positive (DP) thymocytes. This process, known as β-selection, is the first major checkpoint in T-cell development. Signaling through the preTCR terminates TCRβ rearrangements, rescues cells from apoptosis, enables DN thymocytes to differentiate to DP thymocytes, and triggers TCRα rearrangements. In PNAS, Mallis et al. (2) present another advance in the understanding of β-selection.
Two models have been proposed to explain signaling through the preTCR. According to the first model, a self-ligand on thymic stroma, possibly peptide-MHC (pMHC), is required for-or at least contributes to-preTCR signaling. In contrast, the second model proposes that the preTCR transduces signals in a ligandindependent way. This autonomous signaling model is strongly supported by experiments clearly showing that MHC class I or class II is not necessary for thymocytes to progress from DN to DP (3, 4) . Importantly, these two models are not mutually exclusive and, in fact, can be reconciled in a single model that combines key elements of each, based on new results reported by Mallis et al. (2) .
Although preTCR-driven DP development does not absolutely require interaction with pMHC, the possibility remains that the nature of the β-repertoire could be influenced by pMHC (or other self-ligands) binding to the preTCR. Until now, however, there was no actual evidence for such an interaction. Using NMR spectroscopy, Mallis et al. (2) have demonstrated low-affinity, but specific, interactions between the TCRβ subunit of the preTCR and pMHC ligands. The choice of NMR for these studies was predicated on the unique ability of this technique to map contact sites at a per residue basis for weakly interacting protein-protein complexes (K D up to millimolar) that are not amenable to crystallization because of low affinity. The two TCR β-chains investigated derived from αβTCRs N15 and N30, which use different Vβ gene segments to recognize the same pMHC ligand, a vesisular stomatis octapeptide (VSV8) bound to K b . In NMR titration experiments, the addition of unlabeled VSV8/K b to isotope-labeled N15β or N30β resulted in chemical shift changes within only the Vβ domain, involving complementarity-determining region 1 (CDR1), CDR3, and a hydrophobic patch on Vβ that is uniquely exposed in the preTCR but masked by Vα in the αβTCR (Fig.  1A) . Specific Vβ CDR residues identified by NMR as involved in binding VSV8/K b were verified by mutational analysis. However, a limitation of this study is that a complementary analysis of the pMHC ligand was not performed to ascertain whether the isolated N15 and N30 β-chains contact the same-or similar-site on VSV8/K b as they do in the context of the corresponding αβTCRs. Importantly, the ability of TCRβ to bind pMHC when associated with pTα in a complete preTCR was independently demonstrated in situ by micropipette and biomembrane force probe measurements.
To support the biological relevance of these biophysical results, Mallis et al. (2) show that preTCR engagement by pMHC triggers Ca 2+ flux in immature thymocytes transduced with the N15 β-chain, which is critical for TCR signaling. More compellingly, the authors use OP9-DL4 stromal cell cultures to demonstrate that DN thymocyte development and proliferation is impacted by mutations in the preTCR β-chain that reduce affinity for VSV8/K b . Specifically, ∼50% fewer cells bearing such mutations progressed from DN to DP compared with wild-type, implying a significant role for preTCR-pMHC interactions in this developmental transition. It is essential to note that these results do not contradict earlier studies clearly showing that the DN-to-DP transition proceeds in the absence of pMHC ligands (3, 4) . Rather, the findings suggest that preTCR-pMHC interactions may drive DN thymocytes expressing certain β-chains to proliferate more rapidly than ones expressing other β-chains, thereby increasing the representation of these particular β-clonotypes during subsequent TCRα rearrangement. By enriching for β-clonotypes that are more predisposed to binding pMHC, β-selection would serve to optimize the αβTCR repertoire before the DP thymocyte stage.
How does this new model of ligand-dependent DN thymocyte selection fit into current thinking on ligand-independent (autonomous) preTCR signaling? A mechanism to explain preTCR-mediated autonomous signaling has been proposed based on the ability of pTα to form oligomers spontaneously in the absence of ligand engagement (5) . In these experiments, the extracellular domain of pTα was fused to the transmembrane and cytoplasmic domains of the erythropoietin receptor. BAF3 cells transduced with this pTα-erythropoietin receptor chimera demonstrated considerable growth because of self-oligomerization of the extracellular domain of pTα (5). Although it was not firmly established that the intact preTCR (as opposed to pTα alone) also oligomerizes on the cell surface, ligand-independent preTCR self-association on DN thymocytes offers an appealing explanation for autonomous signaling by the preTCR (5, 6) .
Insights into a possible molecular basis for preTCR oligomerization have come from the crystal structure of the extracellular portion of the preTCR (1). In this structure ( Fig. 1 A and  B) , the Ig-like pTα domain interacts exclusively with the TCR Cβ domain via an association mode resembling that between the Cα and Cβ domains of the αβTCR. In addition, two potential preTCR dimers were observed within the crystal lattice. These dimers may be re-examined in the context of preTCR-pMHC binding (2) , with the important caveat that molecular associations in crystal lattices do not necessarily reflect biologically relevant interactions, no matter how enticing these associations may appear.
The first crystallographic preTCR dimer involved a head-to-tail arrangement in which each pTα domain is sandwiched between the Cβ domain of its partner TCR β-chain and the Vβ domain of the other preTCR molecule (Fig. 1C) . This quaternary arrangement, in which the preTCR dimer lies almost parallel to the plane of the membrane, would render the Vβ CDRs inaccessible to MHC or other self-ligands, as required by a ligand-dependent signaling model (2) . The existence of a head-to-tail dimer in solution was supported by site-directed mutagenesis experiments (1). Whether this dimer can also exist on the cell surface, however, depends, at least in part, on constraints imposed by attachment of the extracellular domains of the preTCR to the membrane. In contrast, the second preTCR dimer observed in the crystal involved a sideby-side arrangement in which the two preTCR monomers project upward from the membrane and the Vβ CDRs are fully available to bind potential ligands, as proposed by Mallis et al. (2) (Fig. 1D ). This upright orientation is similar to that of the mature αβTCR.
The side-by-side preTCR dimer was discounted at the time because it was believed that this arrangement would prohibit association of CD3 subunits with the TCR β-chain, based on evidence then available (1). In particular, mutational studies had suggested that the ectodomain of CD3eγ interacts with CC′ and FG loops of the Cβ domain (7), which would place CD3eγ alongside Cβ, thereby sterically preventing formation of the side-by-side preTCR dimer observed in the crystal. These studies relied on cell-based assays to locate TCR-CD3 extracellular contact sites by, for example, measuring the effect of mutations in Cβ on the stability of CR-CD3 complexes reconstituted in transduced lymphoma cells (8) . However, such assays cannot easily distinguish between Cβ mutations that disrupt TCRβ-CD3 contacts directly from mutations that deleteriously affect folding or stability of the TCR itself.
More recently, negative-stain electron microscopy of the TCR-CD3 integral membrane complex revealed that the CD3eγ and CD3eδ subunits are situated underneath the TCR β-chain and TCR α-chain, respectively (Fig.  1B) (9) . This arrangement is consistent with an NMR study identifying the docking site for CD3 on the TCR β-chain, which placed this site at the base of the Cβ domain rather than alongside it (10). Therefore, both electron microscopy and NMR position CD3 between the TCR and T-cell membrane, away from the CC′ and FG loops of Cβ implicated in earlier studies (7, 8) . This location for CD3 is compatible with the side-by-side preTCR crystallographic dimer (1), in which an upright preTCR projects away from the thymocyte membrane, similar to an αβTCR (Fig. 1D) . It is less apparent how CD3 subunits could be accommodated in the head-to-tail preTCR crystallographic dimer (1), in which the dimer is nearly parallel to the membrane (Fig. 1C) . Although this conclusion assumes that CD3 subunits associate with the TCR β-chain in a similar manner irrespective of whether the TCR β-chain is paired with pTα or a TCR α-chain, there is no a priori reason to believe this is not the case, especially because the TCRβ-CD3 association is stabilized by highly conserved interactions between oppositely charged residues in the transmembrane helices of TCRβ and CD3eγ (11) .
It should also be noted that rodent pTα chains possess an N-linked glycan at Asn101 that would block formation of a head-to-tail, but not a sideby-side, dimer because of major steric clashes with the Vβ domain of its dimeric partner (12) . Although human pTα does not have a glycan at this position, we expect rodent and human preTCRs to dimerize in a geometrically comparable fashion, if indeed dimerization is a feature of preTCR function. Additional studies are required to address this and other unresolved issues related to the biophysics of preTCRmediated signaling, as well as to evaluate the extent to which β-selection mediated by preTCR-pMHC interactions contributes to optimizing the αβTCR repertoire in vivo. 
